Welcome to our dedicated page for Progyny news (Ticker: PGNY), a resource for investors and traders seeking the latest updates and insights on Progyny stock.
Progyny, Inc. reports developments in women's health and family building benefits, including fertility care access, employer demand, product expansion, and financial results. The company provides benefit solutions for employers, health plans, and benefit purchasers, combining concierge support, coaching, education, digital tools, and access to a network of fertility and women's health specialists.
Recurring updates include quarterly earnings, financial guidance, selling-season activity, share repurchases, investor conference appearances, and offerings such as Progyny Select, a fully insured supplemental fertility and family building plan for small U.S. employers.
Progyny (Nasdaq: PGNY) released survey results showing strong demand for personalized, human-led guidance in fertility, pregnancy, postpartum, and menopause care.
71% of members reported added stress from their healthcare journey, 43% said stress hurt work performance, and over 70% wanted trusted human support like Progyny Care Advocates (PCAs).
Progyny (Nasdaq: PGNY) announced that its board approved a share repurchase program authorizing buybacks of up to $200 million of common stock. The program will be funded with available cash and may use open-market and Rule 10b5-1 plans, with timing and size depending on market conditions.
Progyny (Nasdaq: PGNY) announced that CEO Pete Anevski and CFO Mark Livingston will speak in a fireside chat at the BofA Securities 2026 Health Care Conference on May 12, 2026, at 11:20 a.m. PT / 2:20 p.m. ET.
A live audiocast and replay will be available on Progyny’s investor relations website.
Progyny (Nasdaq: PGNY) reported record Q1 2026 revenue of $328.5M, gross profit of $83.1M and net income of $24.2M ($0.29 diluted). Adjusted EBITDA was $56.6M. The company repurchased 8.8M shares to date and had 595 clients and ~7.185M average members.
Progyny (NASDAQ: PGNY) will report results for the quarter ended March 31, 2026, after market close on Thursday, May 7, 2026. A conference call will follow at 4:45 p.m. ET (1:45 p.m. PT). A press release will be issued before the call and a live webcast and archived replay will be available on the investor website.
Progyny (Nasdaq: PGNY) launched Progyny Select, the industry’s first fully insured supplemental fertility and women’s health plan for small U.S. employers, announced April 16, 2026. Key features include fixed PEPM pricing, comprehensive coverage (IVF, IUI, genetic testing), concierge care advocates, and support across pregnancy, postpartum, and menopause.
The plan will be distributed via brokers, health plan partners, and agents for implementation in 2027 plan years.
Progyny (NASDAQ:PGNY) marks its 10-year anniversary on April 1, 2026, celebrating growth in women’s health and family building benefits.
The company highlights support for over 470,000 members, more than 600 employers, coverage of 7.2 million lives, and data-driven clinical outcomes improving IVF and menopause access.
Progyny (Nasdaq: PGNY) announced that company executives will participate in investor conferences in March 2026, including Leerink Partners, Barclays Global Healthcare, and KeyBanc Capital Markets.
Specific sessions: CFO Mark Livingston (fireside chat) on March 10 at 10:40 a.m. ET; CEO Pete Anevski (fireside chats) on March 11 at 1:00 p.m. ET and March 17 at 3:00 p.m. ET; COO Melissa Cummings (panel) on March 17 at 12:00 p.m. ET. Live audiocasts and replays will be available in the Events and Presentations section of Progyny's investor relations website.
Progyny (Nasdaq: PGNY) reported 4Q2025 revenue $318.4M (+6.7% YoY) and FY2025 revenue $1.2887B (+10% YoY). Gross profit was $76.9M in 4Q and $304.5M for FY. Net income was $12.5M (4Q) and $58.5M (FY). Adjusted EBITDA was $51.4M (4Q) and $222.1M (FY).
The company generated $210.2M operating cash flow in 2025, repurchased ~6.5M shares (~$160M), ended year with no debt and ~555 clients.
Progyny (Nasdaq: PGNY) will report fourth quarter and full year 2025 results after market close on February 26, 2026.
The company will host a conference call at 4:45 p.m. ET and publish a press release before the call. Dial‑in numbers, passcode 265484, replay through March 5, 2026, and a live webcast/archive are available on the investor website.